Zero-fluoroscopy Approach Versus Fluoroscopic Approach for the Ablation of Paroxysmal Supraventricular Tachycardia (ZFA-PSVT)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03042078|
Recruitment Status : Unknown
Verified February 2017 by Yan Wang, Tongji Hospital.
Recruitment status was: Recruiting
First Posted : February 3, 2017
Last Update Posted : February 6, 2017
|Condition or disease||Intervention/treatment||Phase|
|Paroxysmal Supraventricular Tachycardia||Device: Zero-fluoroscopic ablation Device: Conventional fluoroscopic ablation||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||2200 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Multi-center, Controlled Trial to Compare the Feasibility, Safety and Efficacy of Zero-fluoroscopic Approach With Fluoroscopic Approach for the Ablation of Paroxysmal Supraventricular Tachycardia|
|Study Start Date :||January 2012|
|Estimated Primary Completion Date :||December 2017|
|Estimated Study Completion Date :||December 2018|
Experimental: Zero-fluoroscopic ablation
Paroxysmal supraventricular tachycardia will be ablated under the guidance of Ensite NavX and without the use of fluoroscopy.
Device: Zero-fluoroscopic ablation
Catheter ablation will be performed under the guidance of Ensite NavX and without the use of fluoroscopy.
Active Comparator: Conventional fluoroscopic ablation
Paroxysmal supraventricular tachycardia will be ablated under the guidance of Ensite NavX plus fluoroscopy.
Device: Conventional fluoroscopic ablation
Catheter ablation will be performed under the guidance of Ensite NavX plus fluoroscopy.
- Procedural success rate [ Time Frame: one year ]
- Complications [ Time Frame: one year ]
- Immediate success rate [ Time Frame: one day ]
- Recurrence Rate [ Time Frame: 1 year ]
- Total procedure time [ Time Frame: one day ]
- Fluoroscopy time [ Time Frame: one day ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03042078
|Contact: Yan Wang, PhDfirstname.lastname@example.org|
|Contact: Guangzhi Chen, PhDemail@example.com|
|Wuhan, Hubei, China, 430030|
|Contact: Yan Wang, PhD +86-13697326307 firstname.lastname@example.org|
|Contact: Guangzhi Chen, PhD 86-27-83662842 email@example.com|
|Principal Investigator:||Yan Wang, PhD||Tongji Hospital Wuhan, Hubei China|